bioRxiv preprint doi: https://doi.org/10.1101/2021.05.28.446107; this version posted May 28, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Identification of ubiquitin variants that inhibit the E2 ubiquitin conjugating enzyme, Ube2k Middleton, A.J.1 *, Teyra, J.2, Zhu, J.1, Sidhu, S.S.2, Day, C.L.1 1 Department of Biochemistry, School of Biomedical Sciences, University of Otago, Dunedin 9054, New Zealand 2 The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, 160 College Street, Toronto, Ontario, M5S 3E1, Canada *Author for correspondence Department of Biochemistry School of Biomedical Sciences University of Otago Dunedin 9054 New Zealand Tel: +64 3 479 7870 email:
[email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.05.28.446107; this version posted May 28, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Summary Transfer of ubiquitin to substrate proteins regulates most processes in eukaryotic cells. E2 enzymes are a central component of the ubiquitin machinery, and generally determine the type of ubiquitin signal generated and thus the ultimate fate of substrate proteins. The E2, Ube2k, specifically builds degradative ubiquitin chains on diverse substrates.